Chimpanzee-Plasma-Derived Hepatitis-B Vaccines

https://zenodo.org/doi/10.5281/zenodo.13249977

Today, I submitted this manuscript to Zenodo as a preprint for public review. I’m developing a platform for researchers at qurnec.org to collect and analyze replies on key facts about "Elements," creating AI-generated consensus summaries. This paper does not address vaccine harm but compares public and private statements of officials to determine if they obfuscated the use of chimpanzee plasma in vaccines after AIDS made them less marketable.

Abstract

This paper investigates historical documents to establish a timeline for chimpanzee-plasma-derived Hepatitis-B vaccines. Obscure symposium proceedings, archived during the AIDS epidemic's emergence, uncover internal communications among health officials, providing a comparison to their public statements, similar to the 2023 Slack Message Leak on COVID-19 origins.  A key focus is the 1982 WHO Symposium, held two months after AIDS recognition, where the use of chimpanzee plasma-derived vaccines on humans was discussed, and concerns linking it to AIDS were raised. Despite this, officials publicly claimed all vaccines were made from human plasma with no AIDS link. These vaccines were then banned in many developed countries but continued to be marketed in Africa without safety-testing lots. The symposium's details are available on archive.org.

This paper does not address vaccine safety, but rather calls on the CDC to clarify the reported 5:1 HIV rate ratio between vaccine and placebo recipients in one trial group. Avoiding speculation, it focuses on verifiable points regarding the use of chimpanzee-plasma-derived Hepatitis-B vaccines, and invites public comment and counterclaims, urging individuals to reconcile public and private statements. The study aims to establish a consensus on key facts acknowledged by all parties for inclusion in the final peer-reviewed paper. By documenting engagement or censorship instances, this paper also examines transparency and accountability in public health communications, especially given recent calls for legislation mandating pharmaceutical products and arbitrating truth through pandemic treaties, vaccine passports, and digital IDs.